• Accelerating advances in antibody therapy
    Creasallis wins Integra supports start-ups competition.

Pipettes

Accelerating advances in antibody therapy

Creasallis, a UK-based start-up focused on enhancing the penetration of therapeutic antibodies into tumours, has received a boost from Integra Biosciences. As part of the 'Integra supports start-ups' competition, Creasallis is awarded 50 EVOLVE manual pipettes, GRIPTIPS® pipette tips valued at US $1000, and various lab accessories. This support empowers Creasallis to efficiently pipette volumes ranging from 0.2 to 5000 μl, enhancing its capabilities for ground-breaking research in antibody therapy.

Established in 2021, Creasallis addresses a crucial challenge in antibody therapies -their limited penetration into tumours, often leading to surface-level treatment. The company's patented CreaTap technology aims to overcome this limitation and can be integrated into existing antibodies. The recent prize from Integra allows Creasallis to elevate its laboratory operations, ensuring more accurate and dedicated pipetting for tasks such as cell culture and protein work, ultimately preventing contamination. Dr Joyce Ratti, Head of Protein Sciences at Creasallis, expressed gratitude for the generous prize, emphasising its significant impact on expanding the lab's capabilities and accelerating their innovative research.

More information online


Digital Edition

Lab Asia 32.1 Feb 2025

February 2025

Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...

View all digital editions

Events

SPS Smart Production Solutions Guangzhou

Feb 25 2025 Guanghzou, China

SmartLab Exchange

Feb 25 2025 Amsterdam, Netherlands

Nepal Lab

Feb 27 2025 Kathmandu, Nepal

PITTCON 2025

Mar 01 2025 Boston, MA, USA

IFPAC 2025

Mar 02 2025 Bethesda, MD, USA

View all events